Ocular Involvement in Post-Transplantation Lymphoproliferative Disorder: A Rare Case with Rituximab Hypersensitivity

Jing-yi Liu; Wan-Ting Zhang; Kang Wang; Ying Liu; Lin Wei; Wei Qu; Zhi-Gui Zeng; Zhi-Jun Zhu; Li-Ying Sun

doi:10.12659/AJCR.949884

20 November 2025 : Case report China

Ocular Involvement in Post-Transplantation Lymphoproliferative Disorder: A Rare Case with Rituximab Hypersensitivity

Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis)

Jing-yi Liu

^{AE 1,2,3,4}, Wan-Ting Zhang^{BE 1,2,3,4}, Kang Wang^{D 5}, Ying Liu^{D 1,2,3,4}, Lin Wei^{D 2,3,4}, Wei Qu^{E 2,3,4}, Zhi-Gui Zeng^{DF 2,3,4}, Zhi-Jun Zhu^{D 2,3,4}, Li-Ying Sun^{AB 1,2,3,4*}

DOI: 10.12659/AJCR.949884

Am J Case Rep 2025; 26:e949884

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions Reference

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Diagnosis and treatment of the patient. RTX – rituximab.

Back to the Article

Ocular Involvement in Post-Transplantation Lymphoproliferative Disorder: A Rare Case with Rituximab Hypersensitivity

Your Privacy